◀ Back to HDAC3

BCL2 — HDAC3

Text-mined interactions from Literome

Peterson et al., Mol Cell Biol 2007 (Breast Neoplasms) : SMRT is required for full expression of the ERalpha target genes cyclin D1, BCL-2 , and progesterone receptor but not pS2, and its depletion significantly attenuated estrogen dependent proliferation of MCF-7 cells ... SMRT is required for full expression of the ERalpha target genes cyclin D1, BCL-2 , and progesterone receptor but not pS2, and its depletion significantly attenuated estrogen dependent proliferation of MCF-7 cells
Whitecross et al., Blood 2009 (Lymphoma) : The apoptotic and therapeutic activities of the histone deacetylase inhibitor ( HDACi ) vorinostat are blocked by overexpression of Bcl-2 or Bcl-X ( L )
Martin et al., Mol Pharmacol 2009 : BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing